Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

Clinical trial NCT03072121 · UNKNOWN

Trial details

NCT number: NCT03072121
Sponsor: Jun Li
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease(CAD)

Start date: 2017-06-01
Primary completion: 2018-12-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.